AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Quarter Return
+5.44%
1 Year Return
+18.84%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$180M
AUM Growth
+$180M
(+24%)
Cap. Flow
+$31.5M
Cap. Flow
% of AUM
17.49%
Top 10 Holdings %
Top 10 Hldgs %
21.59%
Holding
287
New
77
Increased
46
Reduced
73
Closed
55
Top Buys
| 1 |
Jazz Pharmaceuticals
JAZZ
|
$4.18M |
| 2 |
Invesco S&P 500 Pure Value ETF
RPV
|
$2.42M |
| 3 |
Coherus Oncology, Inc. Common Stock
CHRS
|
$2.38M |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
$2.37M |
| 5 |
Amylyx Pharmaceuticals
AMLX
|
$2.17M |
Top Sells
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
$4.07M |
| 2 |
Invesco QQQ Trust
QQQ
|
$2.81M |
| 3 |
Invesco NASDAQ 100 ETF
QQQM
|
$2.81M |
| 4 |
Innoviva
INVA
|
$2.07M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
$1.63M |
Sector Composition
| 1 | Healthcare | 59.95% |
| 2 | Real Estate | 10.67% |
| 3 | Financials | 4.01% |
| 4 | Technology | 3.11% |
| 5 | Consumer Discretionary | 2.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Lennar Class A
LEN
$34.5B
| $742K | 0.41% |
5,925
+1,058
| +22% | +$133K |
|
77
FiscalNote
NOTE
$73.2M
| $728K | 0.4% |
+200,000
| New | +$728K |
|
|
NNDM
78
Nano Dimension
NNDM
$300M
| $723K | 0.4% |
250,000
| – | – |
|
|
AMRN
79
Amarin Corp
AMRN
$311M
| $696K | 0.39% |
585,000
+85,000
| +17% | +$101K |
|
80
Gilead Sciences
GILD
$140B
| $655K | 0.36% |
8,500
| – | – |
|
|
MITT
81
AG Mortgage Investment Trust
MITT
$240M
| $642K | 0.36% |
+104,821
| New | +$642K |
|
|
DPRO
82
Draganfly
DPRO
$91.1M
| $640K | 0.36% |
500,000
| – | – |
|
|
PNT
83
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $634K | 0.35% |
+70,000
| New | +$634K |
|
84
Exelixis
EXEL
$10.1B
| $631K | 0.35% |
33,000
| – | – |
|
85
Nuvation Bio
NUVB
$1.02B
| $621K | 0.34% |
345,000
| – | – |
|
86
JPMorgan BetaBuilders Japan ETF
BBJP
$13.8B
| $587K | 0.33% |
11,389
-2,523
| -18% | -$130K |
|
87
Viatris
VTRS
$12.3B
| $549K | 0.3% |
+55,000
| New | +$549K |
|
88
uniQure
QURE
$896M
| $544K | 0.3% |
+47,500
| New | +$544K |
|
89
Equity Lifestyle Properties
ELS
$11.7B
| $543K | 0.3% |
+8,111
| New | +$543K |
|
90
iShares MSCI Australia ETF
EWA
$1.54B
| $520K | 0.29% |
+23,064
| New | +$520K |
|
91
Celldex Therapeutics
CLDX
$1.47B
| $509K | 0.28% |
15,000
| – | – |
|
92
VanEck High Yield Muni ETF
HYD
$3.29B
| $497K | 0.28% |
9,680
+4,840
| +100% | +$248K |
|
93
Cardinal Health
CAH
$35.5B
| $493K | 0.27% |
+5,217
| New | +$493K |
|
94
Aurinia Pharmaceuticals
AUPH
$1.58B
| $484K | 0.27% |
50,000
-27,500
| -35% | -$266K |
|
95
Cigna
CI
$80.3B
| $458K | 0.25% |
1,631
+380
| +30% | +$107K |
|
96
SPDR Bloomberg Convertible Securities ETF
CWB
$4.41B
| $421K | 0.23% |
+6,014
| New | +$421K |
|
97
iShares JPMorgan EM High Yield Bond ETF
EMHY
$494M
| $417K | 0.23% |
11,864
-1,314
| -10% | -$46.2K |
|
98
McKesson
MCK
$85.4B
| $412K | 0.23% |
965
+234
| +32% | +$100K |
|
99
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$13.4B
| $412K | 0.23% |
4,756
+3,465
| +268% | +$300K |
|
100
Invesco S&P 500 BuyWrite ETF
PBP
$290M
| $410K | 0.23% |
18,538
+4,885
| +36% | +$108K |
|